Frontotemporal and striatal SPECT abnormalities in myoclonus-dystonia: Phenotypic and pathogenetic considerations

Neurodegenerative Diseases

Volumn 5, Issue 6, 2008, Pages 355-358

  Papapetropoulos, Spiridon ^a,b   Argyriou, Andreas A ^a,c   Polychronopoulos, Panagiotis ^a   Spyridonidis, Trifonas ^a   Gourzis, Philippos ^a   Chroni, Elisabeth ^a  

^a UNIVERSITY HOSPITAL OF PATRAS   (Greece)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Caudate nucleus; Myoclonus dystonia syndrome; Regional cerebral blood flow; Single photon emission computed tomography

Indexed keywords

CLONAZEPAM; CYSTEINE ETHYL ESTER TC 99M; LEVODOPA; SERTRALINE;

ADULT; ARTICLE; BRAIN BLOOD FLOW; BRAIN PERFUSION; CASE REPORT; CAUDATE NUCLEUS; CENTRAL NERVOUS SYSTEM; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; CORPUS STRIATUM; DYSTONIA; ELECTROMYOGRAM; FRONTAL LOBE; HUMAN; IMAGE ANALYSIS; INTELLIGENCE QUOTIENT; MALE; MYOCLONUS; NEUROIMAGING; NEUROPATHOLOGY; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TEMPORAL LOBE; TREATMENT RESPONSE; WECHSLER INTELLIGENCE SCALE;

ADULT; CORPUS STRIATUM; CYSTEINE; DNA MUTATIONAL ANALYSIS; DYSTONIA; FRONTAL LOBE; HUMANS; MALE; MYOCLONUS; ORGANOTECHNETIUM COMPOUNDS; SARCOGLYCANS; TEMPORAL LOBE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 49849096188     PISSN: 16602854     EISSN: 16602862     Source Type: Journal    
DOI: 10.1159/000119458     Document Type: Article

References (26)

1. Quinn NP: Essential myoclonus and myoclonic dystonia. Mov Disord 1996;11:119-124.
2. Gasser T: Inherited myoclonus-dystonia syndrome. Adv Neurol 1998;78:325-334.
3. Doheny DO, Brin MF, Morrison CE, Smith CJ, Walker RH, Abbasi S, et al: Phenotypic features of myoclonus-dystonia in three kindreds. Neurology 2002;59:1187-1196.
4. Muller B, Hedrich K, Kock N, Dragasevic N, Svetel M, Garrels J, et al: Evidence that paternal expression of the epsilon-sarcoglycan gene accounts for reduced penetrance in myoclonus-dystonia. Am J Hum Genet 2002;71:1303-1311.
5. Michael B, Spitzer RL, Gibbon M, Williams BWJ: Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition (SCID-I/P). New York, Biometrics Research, New York State Psychiatric Institute, 2002.
6. Wechsler D: Wechsler Adult Intelligence Scale-Revised. Manual. Cleveland, Psychological Corporation, 1981.
7. Tatsch K, Asenbaum S, Bartenstein P, Catafau A, Halldin C, Pilowsky LS, et al: European Association of Nuclear Medicine procedure guidelines for brain perfusion SPET using (99m)Tc-labelled radiopharmaceuticals. Eur J Nucl Med Mol Imaging 2002;29:BP36-BP42.
8. Klein C, Schilling K, Saunders-Pullman RJ, et al: A major locus for myoclonus-dystonia maps to chromosome 7q in eight families. Am J Hum Genet 2000;67:1314-1319.
9. Vidailhet M, Tassin J, Durif F, et al: A major locus for several phenotypes of myoclonus-dystonia on chromosome 7q. Neurology 2001;56:1213-1216.
10. Saunders-Pullman R, Ozelius L, Bressman SB: Inherited myoclonus-dystonia. Adv Neurol 2002;89:185-191.
11. Asmus F, Zimprich A, Naumann M, et al: Inherited myoclonus-dystonia syndrome: narrowing the 7q21-q31 locus in German families. Ann Neurol 2001;49:121-124.
12. Nygaard TG, Raymond D, Chen C, et al: Localization of a gene for myoclonus-dystonia to chromosome 7q21-q31. Ann Neurol 1999;46:794-798.
13. 2 dopamine receptor with myoclonus dystonia. Proc Natl Acad Sci USA 1999;96:5173-5176.
14. Doheny D, Danisi F, Smith C, et al: Clinical findings of a myoclonus-dystonia family with two distinct mutations. Neurology 2002;59:1244-1246.
15. Kyllerman M, Sanner G, Forsgren L, Holmgren G, Wahlstrom J: Early-onset dystonia decreasing with development. Case report of two children with familial myoclonic dystonia. Brain Dev 1993;15:295-298.
16. Gaskin ME, Greene AF, Robinson ME, Geisser ME: Negative affect and the experience of chronic pain. J Psychosom Res 1992;36:707-713.
17. Lavigne JV, Schulein MJ, Hahn YS: Psychological aspects of painful medical conditions in children. 2. Personality factors, family characteristics and treatment. Pain 1986;27:147-169.
18. Vila G, Nollet-Clemencon C, de Blic J, Mouren-Simeoni MC, Scheinmann P: Prevalence of DSM IV anxiety and affective disorders in a pediatric population of asthmatic children and adolescents. J Affect Disord 2000;58:223-231.
19. Saunders-Pullman R, Shriberg J, Heiman G, et al: Myoclonus dystonia: possible association with obsessive-compulsive disorder and alcohol dependence. Neurology 2002;58:242-245.
20. Ichinose H, Ohye T, Takahashi E, et al: Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nat Genet 1994;8:236-242.
21. Hewett J, Gonzalez-Agosti C, Slater D, et al: Mutant torsin A, responsible for early-onset torsion dystonia, forms membrane inclusions in cultured neural cells. Hum Mol Genet 2000;9:1403-1413.
22. 2 dopamine receptor gene in myoclonic dystonia and essential myoclonus. Ann Neurol 2000;48:127-128.
23. Delecluse F, Waldemar G, Vestermark S, Paulson OB: Cerebral blood flow deficits in hereditary essential myoclonus. Arch Neurol 1992;49:179-182.
24. Lerner A, Shill H, Hanakawa T, Bushara K, Goldfine A, Hallett M: Regional cerebral blood flow correlates of the severity of writer's cramp symptoms. Neuroimage 2004;21:904-913.
25. Foncke EM, Bour LJ, Speelman JD, Koelman JH, Tijssen MA: Local field potentials and oscillatory activity of the internal globus pallidus in myoclonus-dystonia. Mov Disord 2007;22:369-376.
26. Vander Borght T, De Coene B, Charlet S, Gilliard C, Reynaert C: Unusual depression and Tc-99m ethyl cysteinate dimer SPECT brain uptake. Clin Nucl Med 2001;26:160.